Beckers Hospital Review
JUNE 27, 2025
hospitals are increasingly integrating pharmacists into clinical care, but many are struggling to fill roles and maintain staff, according to the 2024 American Society of Health-System Pharmacists National Survey of Pharmacy Practice in Hospital Settings.
Pharmacy Times
AUGUST 6, 2025
Pharmacies enhance vaccine access and education, offering convenient vaccination opportunities and personalized counseling to counter hesitancy. According to the CDC, national kindergarten vaccination coverage dropped to 93% in the 2023-2024 school year, down from prepandemic levels of approximately 95%. October 2, 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 20, 2025
Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease.
Pharmacy Times
JULY 16, 2025
14,15 Lung Cancer Tarlatamab Significantly Improves Survival in Patients With Small Cell Lung Cancer Post Progression Tarlatamab has shown promising efficacy in relapsed SCLC based on the initial single-arm trial findings, leading to an FDA approval in 2024, but challenges with administration have limited its widespread adoption.
Pharmacy Times
AUGUST 1, 2025
The top pharmacy benefit managers of 2023: market share and trends for the biggest companies—and what’s ahead. April 9, 2024. Here’s How. Until Congress finds the will to act, more states should follow in their footsteps and enact similar PBM reforms that help patients access the care they need when they need it. REFERENCES Fein AJ.
Pharmacy Times
JULY 25, 2025
Last Updated October 26, 2024. Last Updated October 4, 2024. Pneumococcal disease—pneumococcal vaccine recommendations. Accessed July 23, 2025. CDC—AdultVaxView. Vaccination coverage among adults in the United States, National Health Interview Survey, 2022. Accessed July 23, 2025. Hong K, Zhou F, Tsai Y, et al.
Pharmacy Times
JUNE 27, 2025
5 Phase 3 ECHO Trial: A New Frontline Option The approval was supported by data from the phase 3 ECHO trial (NCT02972840), presented at the 2024 European Hematology Association Hybrid Congress. June 21, 2024. Deaths were reported in 5 TN and 6 R/R patients. The trial enrolled 598 patients 65 years or older with TN MCL. Hemasphere.
Expert insights. Personalized for you.
Let's personalize your content